Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Cash & Current Investments (2022 - 2025)

NewGenIvf (NIVF) has disclosed Cash & Current Investments for 4 consecutive years, with $793608.0 as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 45.56% to $793608.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $793608.0 through Dec 2025, down 45.56% year-over-year, with the annual reading at $793608.0 for FY2025, 45.56% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $793608.0 at NewGenIvf, down from $1.5 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $1.5 million in Q4 2024, with the low at $27556.0 in Q4 2022.
  • Average Cash & Current Investments over 4 years is $583252.0, with a median of $423856.0 recorded in 2023.
  • The sharpest move saw Cash & Current Investments surged 2594.33% in 2024, then tumbled 45.56% in 2025.
  • Over 4 years, Cash & Current Investments stood at $27556.0 in 2022, then soared by 96.34% to $54104.0 in 2023, then soared by 2594.33% to $1.5 million in 2024, then crashed by 45.56% to $793608.0 in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $793608.0, $1.5 million, and $54104.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.